Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (D...
Gespeichert in:
| Veröffentlicht in: | Advances in therapy 2023-10, Vol.40 (10), p.4127-4133 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4133 |
|---|---|
| container_issue | 10 |
| container_start_page | 4127 |
| container_title | Advances in therapy |
| container_volume | 40 |
| creator | Venable, Sateria R. Al-Hendy, Ayman |
| description | Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (Dr. Ayman Al-Hendy) and the CEO of the Fibroid Foundation (Sateria Venable) provide their perspectives on the diagnosis and management of UF, including common treatments (e.g., myomectomy or hysterectomy). They also discuss Relugolix combination therapy for UF, noting who could benefit from this treatment and how it works. Podcast audio available for this article. |
| doi_str_mv | 10.1007/s12325-023-02595-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10499739</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2850306299</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-f5b442c65e5ef08578b4420b6546ccc59b4d1def0a01916ac1f363944770b01c3</originalsourceid><addsrcrecordid>eNp9Uc1uEzEQthCIpoUX4IB8LIeFsb3eHy6oiiggtRChVuJmeb2ziatdO9i7JXmMvjEOSSO4cBiNxt_PjPwR8orBWwZQvouMCy4z4CKVrGW2eUJmrCpkloo_JTMoc5ZxUf04Iacx3gFwKGX1nJyIUhYVFGxGHm5HDNYhvbRN8LaN7-kFXfjW6DhS7-hCjxbdSLVr6WK1jdZYnV4xxDWa0d5j3LGusbVG9_RaO73E4VGg6Vf8dQRvVhj0ekvPv2M_LX1vN3Tuh8a6tCJ5HOA3L8izTvcRXx76Gbm9_Hgz_5xdffv0ZX5xlZk8L8esk02ec1NIlNhBJctqN0NTyLwwxsi6yVvWJkgDq1mhDetEIeqkLaEBZsQZ-bD3XU_NgK1JRwfdq3Wwgw5b5bVV_yLOrtTS3ysGeV2Xok4O5weH4H9OGEc12Giw77VDP0XFKwkCCl7vqHxPNcHHGLA77mGgdmGqfZgqhan-hKk2SfT67wuPksf0EkHsCTFBbolB3fkpuPRr_7P9DS6MrUs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2850306299</pqid></control><display><type>article</type><title>Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)</title><source>Springer Nature - Complete Springer Journals</source><creator>Venable, Sateria R. ; Al-Hendy, Ayman</creator><creatorcontrib>Venable, Sateria R. ; Al-Hendy, Ayman</creatorcontrib><description>Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (Dr. Ayman Al-Hendy) and the CEO of the Fibroid Foundation (Sateria Venable) provide their perspectives on the diagnosis and management of UF, including common treatments (e.g., myomectomy or hysterectomy). They also discuss Relugolix combination therapy for UF, noting who could benefit from this treatment and how it works. Podcast audio available for this article.</description><identifier>ISSN: 0741-238X</identifier><identifier>ISSN: 1865-8652</identifier><identifier>EISSN: 1865-8652</identifier><identifier>DOI: 10.1007/s12325-023-02595-x</identifier><identifier>PMID: 37568061</identifier><language>eng</language><publisher>Cheshire: Springer Healthcare</publisher><subject>Cardiology ; Commentary ; Endocrinology ; Internal Medicine ; Medicine ; Medicine & Public Health ; Oncology ; Pharmacology/Toxicology ; Rheumatology</subject><ispartof>Advances in therapy, 2023-10, Vol.40 (10), p.4127-4133</ispartof><rights>The Author(s) 2023. corrected publication 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-f5b442c65e5ef08578b4420b6546ccc59b4d1def0a01916ac1f363944770b01c3</citedby><cites>FETCH-LOGICAL-c447t-f5b442c65e5ef08578b4420b6546ccc59b4d1def0a01916ac1f363944770b01c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12325-023-02595-x$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12325-023-02595-x$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37568061$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Venable, Sateria R.</creatorcontrib><creatorcontrib>Al-Hendy, Ayman</creatorcontrib><title>Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)</title><title>Advances in therapy</title><addtitle>Adv Ther</addtitle><addtitle>Adv Ther</addtitle><description>Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (Dr. Ayman Al-Hendy) and the CEO of the Fibroid Foundation (Sateria Venable) provide their perspectives on the diagnosis and management of UF, including common treatments (e.g., myomectomy or hysterectomy). They also discuss Relugolix combination therapy for UF, noting who could benefit from this treatment and how it works. Podcast audio available for this article.</description><subject>Cardiology</subject><subject>Commentary</subject><subject>Endocrinology</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Pharmacology/Toxicology</subject><subject>Rheumatology</subject><issn>0741-238X</issn><issn>1865-8652</issn><issn>1865-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp9Uc1uEzEQthCIpoUX4IB8LIeFsb3eHy6oiiggtRChVuJmeb2ziatdO9i7JXmMvjEOSSO4cBiNxt_PjPwR8orBWwZQvouMCy4z4CKVrGW2eUJmrCpkloo_JTMoc5ZxUf04Iacx3gFwKGX1nJyIUhYVFGxGHm5HDNYhvbRN8LaN7-kFXfjW6DhS7-hCjxbdSLVr6WK1jdZYnV4xxDWa0d5j3LGusbVG9_RaO73E4VGg6Vf8dQRvVhj0ekvPv2M_LX1vN3Tuh8a6tCJ5HOA3L8izTvcRXx76Gbm9_Hgz_5xdffv0ZX5xlZk8L8esk02ec1NIlNhBJctqN0NTyLwwxsi6yVvWJkgDq1mhDetEIeqkLaEBZsQZ-bD3XU_NgK1JRwfdq3Wwgw5b5bVV_yLOrtTS3ysGeV2Xok4O5weH4H9OGEc12Giw77VDP0XFKwkCCl7vqHxPNcHHGLA77mGgdmGqfZgqhan-hKk2SfT67wuPksf0EkHsCTFBbolB3fkpuPRr_7P9DS6MrUs</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Venable, Sateria R.</creator><creator>Al-Hendy, Ayman</creator><general>Springer Healthcare</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20231001</creationdate><title>Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)</title><author>Venable, Sateria R. ; Al-Hendy, Ayman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-f5b442c65e5ef08578b4420b6546ccc59b4d1def0a01916ac1f363944770b01c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cardiology</topic><topic>Commentary</topic><topic>Endocrinology</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Pharmacology/Toxicology</topic><topic>Rheumatology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Venable, Sateria R.</creatorcontrib><creatorcontrib>Al-Hendy, Ayman</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Advances in therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Venable, Sateria R.</au><au>Al-Hendy, Ayman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)</atitle><jtitle>Advances in therapy</jtitle><stitle>Adv Ther</stitle><addtitle>Adv Ther</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>40</volume><issue>10</issue><spage>4127</spage><epage>4133</epage><pages>4127-4133</pages><issn>0741-238X</issn><issn>1865-8652</issn><eissn>1865-8652</eissn><abstract>Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (Dr. Ayman Al-Hendy) and the CEO of the Fibroid Foundation (Sateria Venable) provide their perspectives on the diagnosis and management of UF, including common treatments (e.g., myomectomy or hysterectomy). They also discuss Relugolix combination therapy for UF, noting who could benefit from this treatment and how it works. Podcast audio available for this article.</abstract><cop>Cheshire</cop><pub>Springer Healthcare</pub><pmid>37568061</pmid><doi>10.1007/s12325-023-02595-x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0741-238X |
| ispartof | Advances in therapy, 2023-10, Vol.40 (10), p.4127-4133 |
| issn | 0741-238X 1865-8652 1865-8652 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10499739 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Cardiology Commentary Endocrinology Internal Medicine Medicine Medicine & Public Health Oncology Pharmacology/Toxicology Rheumatology |
| title | Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T01%3A22%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uterine%20Fibroids:%20A%20Podcast%20on%20Patient%20and%20Physician%20Perspectives%20on%20Medical%20Management%20and%20a%20New%20Medical%20Therapy%20(Relugolix%20Combination%20Therapy)&rft.jtitle=Advances%20in%20therapy&rft.au=Venable,%20Sateria%20R.&rft.date=2023-10-01&rft.volume=40&rft.issue=10&rft.spage=4127&rft.epage=4133&rft.pages=4127-4133&rft.issn=0741-238X&rft.eissn=1865-8652&rft_id=info:doi/10.1007/s12325-023-02595-x&rft_dat=%3Cproquest_pubme%3E2850306299%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2850306299&rft_id=info:pmid/37568061&rfr_iscdi=true |